Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 3.04

Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res (2000) 2.16

Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol (2002) 1.61

The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47

CNS infection with Chlamydia pneumoniae complicated by multiple strokes. J Neurol (2002) 1.41

Multiple sclerosis and Chlamydia pneumoniae. Ann Neurol (2000) 1.37

In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results? J Clin Microbiol (2005) 1.33

PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids. Clin Diagn Lab Immunol (2002) 1.27

Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun (2003) 1.10

Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol (2000) 1.05

Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05

Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci (2012) 1.04

Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis. Clin Exp Immunol (2009) 0.93

Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy. Infect Immun (1999) 0.91

Chlamydia: a role for multiple sclerosis or more confusion? Ann Neurol (1999) 0.91

Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? J Clin Microbiol (2000) 0.91

Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. J Exp Med (2002) 0.90

Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep (2002) 0.87

Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. BMC Infect Dis (2006) 0.86

B cells in multiple sclerosis. Front Biosci (2004) 0.86

PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids. Clin Diagn Lab Immunol (2001) 0.85

Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun (2005) 0.85

Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol (2010) 0.84

The effect of smoking on the symptoms and progression of multiple sclerosis: a review. J Inflamm Res (2010) 0.84

Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders. Interdiscip Perspect Infect Dis (2010) 0.83

Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis. Clin Diagn Lab Immunol (2002) 0.83

Role of pathogens in multiple sclerosis. Int Rev Immunol (2013) 0.82

Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Ann Neurol (2000) 0.81

Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls. PLoS One (2009) 0.81

Amplification of autoimmune disease by infection. Arthritis Res Ther (2005) 0.81

Serum DNA motifs predict disease and clinical status in multiple sclerosis. J Mol Diagn (2010) 0.80

Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79

Using animal models to determine the significance of complement activation in Alzheimer's disease. J Neuroinflammation (2004) 0.79

The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol (2010) 0.79

Is Chlamydia pneumoniae present in cerebrospinal fluid of multiple sclerosis patients? Clin Diagn Lab Immunol (2003) 0.78

Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One (2014) 0.78

Evidence for horizontal gene transfer between Chlamydophila pneumoniae and Chlamydia phage. Bacteriophage (2014) 0.77

in silico analyses of metabolic pathway and protein interaction network for identification of next gen therapeutic targets in Chlamydophila pneumoniae. Bioinformation (2013) 0.77

Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep (2016) 0.76

Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? Ann Neurol (2000) 0.76

Chlamydia, Rickettsia, and antibiotic treatment of multiple sclerosis. Ann Neurol (2000) 0.75

Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response. Cell Mol Immunol (2010) 0.75

No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis. J Neuroimmunol (2010) 0.75

Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis. Ann Neurol (2000) 0.75

Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA. Front Cell Infect Microbiol (2017) 0.75

Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis. Ann Neurol (2001) 0.75

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J Clin Microbiol (1988) 4.25

Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00

Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J (2001) 3.80

bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (1994) 3.34

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet (1988) 3.32

Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15

CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85

Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science (1998) 2.84

Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A (2000) 2.83

Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62

Novel fluorescent protein from Discosoma coral and its mutants possesses a unique far-red fluorescence. FEBS Lett (2000) 2.61

Measuring nicotine dependence among high-risk adolescent smokers. Addict Behav (1996) 2.54

Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J (1999) 2.45

Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci U S A (1999) 2.18

Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J (1994) 2.16

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci U S A (1990) 2.08

Estimation of the cortical functional connectivity with the multimodal integration of high-resolution EEG and fMRI data by directed transfer function. Neuroimage (2005) 2.06

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04

Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res (1998) 2.00

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol (1991) 2.00

Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98

harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J (1997) 1.97

WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J Biol Chem (1998) 1.93

Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92

Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92

Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91

Estimation of in vivo human brain-to-skull conductivity ratio from simultaneous extra- and intra-cranial electrical potential recordings. Clin Neurophysiol (2005) 1.87

Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1988) 1.86

Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80

Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J (2000) 1.78

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78

Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76

Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. J Acquir Immune Defic Syndr (1989) 1.75

Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74

Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology (2000) 1.71

Epidermal growth factor. Physical and chemical properties. J Biol Chem (1972) 1.69

Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66

Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64

Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63

Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase. Mol Cell Biol (2001) 1.61

New variant of cytochrome b5 reductase deficiency (b5RKurashiki) in red cells, platelets, lymphocytes, and cultured fibroblasts with congenital methemoglobinemia, mental and neurological retardation, and skeletal anomalies. Am J Hematol (1992) 1.61

Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem (1996) 1.61

Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59

bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation. J Immunol (1993) 1.57

Synthesis of (3H)DNA complementary to ovalbumin messenger RNA: evidence for limited copies of the ovalbumin gene in chick oviduct. Proc Natl Acad Sci U S A (1973) 1.52

Defects in ZnO nanorods prepared by a hydrothermal method. J Phys Chem B (2006) 1.51

Lens alpha-crystallin: chaperone-like properties. Methods Enzymol (1998) 1.46

A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone. Br J Dermatol (2015) 1.46

Epidermal growth factor: high and low molecular weight forms. Proc Natl Acad Sci U S A (1970) 1.42

Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42

Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer (2006) 1.41

Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41

bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40

Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40

The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39

DNA triple-helix specific intercalators as antigene enhancers: unfused aromatic cations. Biochemistry (1993) 1.34

Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J (1993) 1.34

Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology (1990) 1.33

Cloning, expression, and characterization of the Escherichia coli K-12 rfaD gene. J Bacteriol (1990) 1.33

A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene (2010) 1.33

A potential source of electrophoretic artifacts in polyacrylamide gels. Biochim Biophys Acta (1967) 1.28

Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol (2001) 1.28

Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics (1998) 1.25

TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus (2010) 1.25

Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother (1987) 1.23

Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis (1996) 1.22

Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes. Cancer Chemother Pharmacol (2000) 1.22

A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. Biochem Biophys Res Commun (1987) 1.20

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20

Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci (2001) 1.20

Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques. J Virol (1990) 1.20

Bedside tracheostomy in the intensive care unit: a prospective randomized trial comparing open surgical tracheostomy with endoscopically guided percutaneous dilational tracheotomy. Laryngoscope (2001) 1.19

In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19

Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis. AIDS Res Hum Retroviruses (1987) 1.19

Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic. Virology (1986) 1.18

Assessing cortical functional connectivity by linear inverse estimation and directed transfer function: simulations and application to real data. Clin Neurophysiol (2004) 1.18

Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J Clin Invest (1973) 1.17

Physical and chemical properties of Moloney murine leukemia virus p30 protein: a major core structural component exhibiting high helicity and self-association. J Mol Biol (1976) 1.17

The role of cyclooxygenase-2 in prostate cancer. Urology (2001) 1.16

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol (2002) 1.15

Purification, gene cloning, and sequence analysis of an L-isoaspartyl protein carboxyl methyltransferase from Escherichia coli. J Biol Chem (1991) 1.15

Characterization of the binding protein for epidermal growth factor. J Biol Chem (1974) 1.15

Purification and properties of clostridiopeptidase B (Clostripain). J Biol Chem (1968) 1.14

Blockade of a retinal cGMP-gated channel by polyamines. J Gen Physiol (1999) 1.14

Anomalous transport properties and phase diagram of the FeAs-based SmFeAsO1-xFx superconductors. Phys Rev Lett (2008) 1.14

Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology (1990) 1.14

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1987) 1.13

Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol (1990) 1.13

Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. J Clin Endocrinol Metab (2000) 1.13

CSF-1 regulation of osteoclastogenesis for tooth eruption. J Dent Res (2005) 1.13

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene (2007) 1.12

ACTH and MSH production by a single cloned mouse pituitary tumor cell line. Endocrinology (1973) 1.11

Imaging functional brain connectivity patterns from high-resolution EEG and fMRI via graph theory. Psychophysiology (2007) 1.11